Results 31 to 40 of about 89,492 (273)

Metal Organic Frameworks: Synthesis and Application

Molecules, 2020
The concept of metal−organic frameworks (MOFs) was first introduced in 1990; nowadays they are among the most promising novel materials [...]
Victoria F. Samanidou, Eleni A. Deliyanni   +1 more
doaj   +1 more source

A Facile and General Approach to Enhance Water Resistance of Metal-Organic Frameworks by the Post-Modification with Aminopropyltriethoxylsilane

, 2022
The water sensitivity of metal-organic frameworks (MOFs) as a common and crucial issue has greatly hindered their practical applications. Here, we present a facile and general approach to improve the water resistance of a typical MOF, i.e., CuBTC [Cu3 ...
Jianmei Gu, Qingyu Ma, Jianquan Li
core   +1 more source

Properties of Metal-Doped Covalent Organic Frameworks and Their Interactions with Sulfur Dioxide

Journal of Chemistry, 2018
Covalent organic frameworks are unique for their highly open architecture and attractive for use as promising gas adsorption and storage carriers. In this work, density functional theory calculations have been performed to investigate the properties of ...
Ju Wang, Jia Wang, Wenchang Zhuang, Xiaoqin Shi, Xihua Du   +4 more
doaj   +1 more source

Solvent-Free Synthesis of Metal-Organic Frameworks Using Low-Melting Metal Salts

, 2022
Metal-organic frameworks (MOFs) are porous, crystalline materials constructed from organic linkers and inorganic nodes with myriad potential applications in chemical separations, catalysis, drug delivery, and beyond.
Tristan, Pitt, Phillip, Milner, Kyle, Lancaster, Melissa, Bollmeyer, Tyler, Azbell, Christina, Cong   +5 more
core   +1 more source

Quantum Metal‐Organic Frameworks

Small Science
Quantum materials and metal‐organic framework (MOFs) materials describe two attractive research areas in physics and chemistry. Yet, with very few exceptions, these fields have been developed with little overlap.
Zhehao Huang, Richard Matthias Geilhufe
doaj   +1 more source

Frustrated flexibility in metal-organic frameworks

Nature Communications, 2021
Responsiveness in metal-organic frameworks involving amorphous phases remains poorly understood. Here, the authors demonstrate MOFs that reversibly switch between well-defined crystalline and structurally degenerate amorphous states mediated by competing
Roman Pallach, Julian Keupp, Kai Terlinden, Louis Frentzel-Beyme, Marvin Kloß, Andrea Machalica, Julia Kotschy, Suresh K. Vasa, Philip A. Chater, Christian Sternemann, Michael T. Wharmby, Rasmus Linser, Rochus Schmid, Sebastian Henke   +13 more
doaj   +1 more source

Stability of Metal–Organic Frameworks: Recent Advances and Future Trends

Engineering Proceedings, 2023
In recent years, metal–organic frameworks (MOFs) have gained a lot of attention from researchers because of their potential applications in gas separation, storage, catalysis, as well as sensing.
Lance Phillip L. Mosca, Andrew B. Gapan, Rica Angela Angeles, Edgar Clyde R. Lopez   +3 more
doaj   +1 more source

The (Glg)ABCs of cyanobacteria: modelling of glycogen synthesis and functional divergence of glycogen synthases in Synechocystis sp. PCC 6803

FEBS Letters, EarlyView.
We reconstituted Synechocystis glycogen synthesis in vitro from purified enzymes and showed that two GlgA isoenzymes produce glycogen with different architectures: GlgA1 yields denser, highly branched glycogen, whereas GlgA2 synthesizes longer, less‐branched chains.
Kenric Lee, Dimitrios Bekiari, Sofia Doello, Karl Forchhammer   +3 more
wiley   +1 more source

Metal-organic frameworks as catalytic selectivity regulators for organic transformations

, 2021
Selective organic transformations using metal-organic frameworks (MOFs) and MOF-based heterogeneous catalysts have been an intriguing but challenging research topic in both the chemistry and materials communities.
Tang, Zhiyong, Zhang, Xiaofei, Zhao, Meiting, Zhu, Yanfei, Long, Chang, Guo, Jun, Qin, Yutian   +6 more
core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source